Santiago Escrivá de Romaní

Santiago Escrivá de Romaní is an oncologist at the Vall d’Hebron Institute of Oncology, recognized for his significant contributions to breast cancer research. He has participated in groundbreaking studies on antibody-drug conjugates (ADCs), which are innovative therapies designed to deliver chemotherapy directly to tumor cells, enhancing treatment efficacy while minimizing side effects. His work emphasizes the potential of ADCs as a transformative approach in oncology, marking a pivotal shift towards more targeted treatments.